Lumature Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.53M Sell
9,269
-61
-0.7% -$9.85K 0.91% 27
2023
Q1
$1.45M Buy
9,330
+274
+3% +$44.2K 0.81% 26
2022
Q4
$1.6M Sell
9,056
-380
-4% -$65.6K 0.89% 21
2022
Q3
$1.54M Sell
9,436
-142
-1% -$24K 0.83% 21
2022
Q2
$1.7M Sell
9,578
-666
-7% -$119K 0.76% 22
2022
Q1
$1.82M Buy
10,244
+2,816
+38% +$479K 0.73% 28
2021
Q4
$1.27M Buy
7,428
+510
+7% +$83.5K 0.49% 41
2021
Q3
$1.12M Buy
6,918
+600
+9% +$102K 0.46% 44
2021
Q2
$1.04M Buy
6,318
+801
+15% +$133K 0.43% 45
2021
Q1
$907K Buy
5,517
+1,766
+47% +$286K 0.48% 44
2020
Q4
$590K Buy
+3,751
New +$554K 0.56% 51

Other funds holding JNJ

Lumature Wealth Partners's JNJ Position: Q2 2023 in Review

Lumature Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 0.65% in Q2 2023, selling an estimated $9.85K and leaving 9,269 shares worth $1.53M. The position accounts for 0.91% of the portfolio, ranked #27.

Lumature Wealth Partners first reported a position in JNJ in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.82M in Q1 2022. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Lumature Wealth Partners held 9,269 shares of Johnson & Johnson worth $1.53M as of Q2 2023.
  • Lumature Wealth Partners sold 61 Johnson & Johnson shares in Q2 2023, an estimated $9.85K.
  • Johnson & Johnson made up 0.91% of Lumature Wealth Partners's portfolio in Q2 2023, its #27 holding.
  • Lumature Wealth Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 11 quarters since.
  • Lumature Wealth Partners's Johnson & Johnson position peaked at $1.82M in Q1 2022.
  • 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.